All News #Library
Rare Diseases
Myrtelle Share Interim Ph1/2 Gene Therapy Data In Canavan Disease
06 Oct 2025 //
PR NEWSWIRE
Myrtelle to Present Insights on FDA`s START at ASGCT 2025
13 May 2025 //
PR NEWSWIRE
Myrtelle Reports NAA Reduction in Canavan Disease Gene Therapy Trial
01 Oct 2024 //
PR NEWSWIRE
Moderna and Myrtelle among those picked for FDA rare disease programme
06 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY

Market Place
Sourcing Support